Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 4/20 | 0.58 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.48 |
| ▸ | GLP1R | P43220 | 8/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18375484 | 0.88 | ALB (0.56) | ALBFOLH1NOD1GLP1RSMN1; SMN2 | |
| SCHEMBL12964947 | 0.87 | ALB (0.55) | ALBFOLH1NOD1GLP1RSMN1; SMN2 | |
| SCHEMBL17040366 | 0.86 | ALB (0.55) | ALBFOLH1NOD1GLP1RSMN1; SMN2 | |
| SCHEMBL23157341 | 0.86 | GLP1R (0.54) | ALBFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL21110602 | 0.86 | GLP1R (0.54) | ALBFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL23157321 | 0.86 | GLP1R (0.54) | ALBFOLH1NOD1GLP1REPHX2 | |
| SCHEMBL15451405 | 0.84 | NOD1 (0.62) | ALBFOLH1NOD1GLP1R | |
| SCHEMBL14685805 | 0.84 | ALB (0.52) | ALBFOLH1NOD1GLP1RSMN1; SMN2 | |
| SCHEMBL17040363 | 0.84 | ALB (0.52) | ALBFOLH1NOD1GLP1RSMN1; SMN2 | |
| SCHEMBL17359223 | 0.84 | ALB (0.52) | ALBFOLH1NOD1GLP1RSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963496-B2 | Stable glucagon analogues and use for treatment of hypoglycaemia | NOVO NORDISK A/S (DK) | 2018-05-08 | — | — | US | disclosed |